In short
This article discusses the use of Metoclopramide Hydrochloride Anhydrous in clinical trials for cancer treatment. Metoclopramide is a medication commonly used to treat nausea and vomiting, but researchers are exploring its potential benefits in cancer therapy. The trials mentioned here focus on colorectal cancer and breast cancer, investigating how Metoclopramide may be used alongside other treatments to improve patient outcomes.
At a glance
- Drug Name
- Metoclopramide Hydrochloride Anhydrous
- Cancer Types Studied
- Colorectal cancer, HER2-positive breast cancer
- Administration
- Oral tablets
- Maximum Daily Dose
- 30 mg
- Treatment Duration
- Up to 30 days in one trial, up to 18 weeks in another
- Main Objectives
- Assess treatment effectiveness, evaluate progression-free survival, determine safety and tolerability, monitor quality of life
- Key Endpoints
- Pathologic complete remission, progression-free survival, adverse events, quality of life measures
- Eligibility Criteria
- Confirmed cancer diagnosis, specific performance status, adequate organ function
- Exclusion Criteria
- Certain medical conditions, prior treatments, pregnancy or breastfeeding
What is Metoclopramide Hydrochloride Anhydrous?
Metoclopramide Hydrochloride Anhydrous is an active substance used in various medications. It belongs to a class of drugs known as antiemetics and gastroprokinetics. This means it helps prevent nausea and vomiting while also improving the movement of food through the digestive system.
What is Metoclopramide Used For?
Metoclopramide is primarily used to treat and prevent various gastrointestinal issues. Some of its main applications include:
- Preventing nausea and vomiting, especially in patients undergoing chemotherapy or experiencing side effects from other medications
- Treating gastroesophageal reflux disease (GERD)
- Improving symptoms of gastroparesis (delayed stomach emptying)
- Managing nausea and vomiting associated with migraines
In clinical trials, metoclopramide is sometimes used as an auxiliary medication to manage potential side effects of other treatments.
How is Metoclopramide Administered?
Metoclopramide is available in various forms, including:
- Tablets (e.g., Metoclopramide Accord 10 mg tablets, Metoclopramide "Orifarm" tablets)
- Oral solution
- Injectable solution for intravenous or intramuscular use
The most common route of administration is oral, typically in tablet form.
Dosage Information
The dosage of metoclopramide can vary depending on the specific condition being treated and the individual patient. However, based on the clinical trial data, some general dosage information includes:
- Maximum daily dose: 30 mg
- Typical tablet strength: 10 mg
- Treatment duration: Can vary, but in the clinical trials mentioned, it ranged from 30 days to 18 weeks
It's important to note that dosage should always be determined by a healthcare professional based on the individual patient's needs and medical condition.
Potential Side Effects
Like all medications, metoclopramide can cause side effects. Some potential side effects may include:
- Drowsiness or dizziness
- Restlessness or agitation
- Diarrhea
- Headache
- In rare cases, movement disorders or muscle stiffness
It's important to report any unusual or severe side effects to your healthcare provider promptly.
Precautions and Considerations
When using metoclopramide, there are several important precautions to keep in mind:
- Inform your doctor about any existing medical conditions, especially any history of movement disorders or gastrointestinal problems
- Metoclopramide may interact with other medications, so inform your healthcare provider about all drugs you're taking
- Avoid alcohol while taking metoclopramide, as it can increase side effects
- Use caution when driving or operating machinery, as metoclopramide can cause drowsiness
Ongoing Research
Metoclopramide continues to be studied in various clinical settings. In the clinical trials mentioned, it was used as an auxiliary medication in studies involving patients with colorectal cancer and breast cancer. This highlights its potential role in managing side effects associated with cancer treatments, particularly chemotherapy-induced nausea and vomiting.
As research progresses, we may gain more insights into the optimal use of metoclopramide in different patient populations and treatment scenarios.